Also Matthew Paul’s from Strongbridge was suggested :
You decide what happened to him ?
”Paul's, CEO of Strongbridge (NASDAQ: SBBP) since August 2014, has also stepped down as a member of the company's board.The action comes two days before Strongbridge, which focuses on therapies to treat rare diseases, was set to announce its third quarter financial results. The company posted revenue of $10.4 million on a net loss of $26.7 million during the first six months of 2019.”
Ann: Long COVID-19 strategic collaboration with US Experts, page-107
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
